• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,308.26
  • 0.23 %
  • $87.63
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
SAB Biotherapeutics, Inc. (SABSW) Ownership

SAB Biotherapeutics, Inc. (SABSW) Ownership

NASDAQ Currency in USD Disclaimer

Stock Price

$0.08

$0.02

(35.14%)

Day's range
$0.05
Day's range
$0.08
Recent Quarter Total Invested

$59,462

$15,663.00
Recent Quarter Institutional Ownership Percentage

11.89%

-$7.77
Total Invested of Last Quarter

$43,799

Ownership Percentage of Last Quarter

19.66%

SAB Biotherapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LMR PARTNERS LLP 08/14/2024 539,588 $25,576   0.00% 5.84%
SHAOLIN CAPITAL MANAGEMENT LLC 08/14/2024 249,143 $11.81 M   -14.96% 2.70%
MORGAN STANLEY 10/17/2024 146,439 $6,941   -1.68% 1.58%
YAKIRA CAPITAL MANAGEMENT, INC. 08/13/2024 108,485 $5,142   0.00% 1.17%
MILLENNIUM MANAGEMENT LLC 08/14/2024 62,500 $2,962   0.00% 0.68%
WALLEYE CAPITAL LLC 08/14/2024 23,258 $1,102   0.00% 0.25%
WALLEYE TRADING LLC 08/14/2024 15,505 $735   0.00% 0.17%
WOLVERINE ASSET MANAGEMENT LLC 08/01/2024 15,319 $726   -32.76% 0.17%
NEWEDGE ADVISORS, LLC 08/16/2024 1,072 $50   0.00% 0.01%
BANK OF AMERICA CORP /DE/ 08/14/2024 200 $9   100.00% 0.00%
UBS GROUP AG 08/14/2024 56 $3   100.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 08/13/2024 48 $2   0.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/15/2024 0 $0   -100.00% 0.00%

SAB Biotherapeutics, Inc.institutional Ownership - Frequently Asked Questions

  • Who are the largest shareholders of SABSW shares?

    During the previous two years, 7 institutional investors and hedge funds held shares of SAB Biotherapeutics, Inc.. The most heavily invested institutionals were:

    Shaolin Capital Management LLC: 0

    LMR Partners LLP: 0

    MORGAN STANLEY: 146,439

    Walleye Trading LLC: 15,505

    BANK OF AMERICA CORP /DE/: 200

    UBS Group AG: 56

  • What percentage of SAB Biotherapeutics, Inc. stock is owned by institutional investors?

    11.89% of SAB Biotherapeutics, Inc. stock is owned by institutional investors.

  • How much institutional buying is happening at SABSW ?

    Institutional investors have bought a total of 162,200 shares in the last 24 months. This purchase volume represents approximately $12,976 in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.